Cargando…

Computational analysis of the mesenchymal signature landscape in gliomas

BACKGROUND: Epithelial to mesenchymal transition, and mimicking processes, contribute to cancer invasion and metastasis, and are known to be responsible for resistance to various therapeutic agents in many cancers. While a number of studies have proposed molecular signatures that characterize the sp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Celiku, Orieta, Tandle, Anita, Chung, Joon-Yong, Hewitt, Stephen M., Camphausen, Kevin, Shankavaram, Uma
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345226/ https://www.ncbi.nlm.nih.gov/pubmed/28279210 http://dx.doi.org/10.1186/s12920-017-0252-7

Ejemplares similares

Visualizing Molecular Profiles of Glioblastoma with GBM-BioDP
por: Celiku, Orieta, et al.
Publicado: (2014)

Molecular profiling of MPS1 gene silencing in U251 glioma cell line
por: Shankavaram, Uma, et al.
Publicado: (2015)

StRAP: An Integrated Resource for Profiling High-Throughput Cancer Genomic Data from Stress Response Studies
por: Johnson, Seth, et al.
Publicado: (2012)

Modulation of miR-21 signaling by MPS1 in human glioblastoma
por: Maachani, Uday B., et al.
Publicado: (2015)

FOXM1 and STAT3 interaction confers radioresistance in glioblastoma cells
por: Maachani, Uday B., et al.
Publicado: (2016)

Cancer-Specific Immune Prognostic Signature in Solid Tumors and Its Relation to Immune Checkpoint Therapies
por: Das, Shaoli, et al.
Publicado: (2020)

Mitotic Protein Kinase 1: Role in Spindle Assembly Checkpoint Revisited
por: Tandle, Anita, et al.
Publicado: (2016)

Pan-Cancer Analysis of Potential Synthetic Lethal Drug Targets Specific to Alterations in DNA Damage Response
por: Das, Shaoli, et al.
Publicado: (2019)

Glioma-BioDP: database for visualization of molecular profiles to improve prognosis of brain cancer
por: Deng, Xiang, et al.
Publicado: (2023)

Molecular profiling indicates orthotopic xenograft of glioma cell lines simulate a subclass of human glioblastoma
por: Shankavaram, Uma T, et al.
Publicado: (2012)

In silico Drug Repurposing to combat COVID-19 based on Pharmacogenomics of Patient Transcriptomic Data
por: Das, Shaoli, et al.
Publicado: (2020)

Novel Murine Biomarkers of Radiation Exposure Using An Aptamer-Based Proteomic Technology
por: Sproull, Mary, et al.
Publicado: (2021)

Computational modeling demonstrates that glioblastoma cells can survive spatial environmental challenges through exploratory adaptation
por: Celiku, Orieta, et al.
Publicado: (2019)

The Next Frontier in Health Disparities—A Closer Look at Exploring Sex Differences in Glioma Data and Omics Analysis, from Bench to Bedside and Back
por: Diaz Rosario, Maria, et al.
Publicado: (2022)

DDRE-08. NRF2/GLUTATHIONE METABOLISM AS A NOVEL THERAPEUTIC TARGET FOR IDH1-MUTATED GLIOMA
por: Liu, Yang, et al.
Publicado: (2021)

Synthetic Lethal Drug Combinations Targeting Proteasome and Histone Deacetylase Inhibitors in TP53-Mutated Cancers
por: Das, Shaoli, et al.
Publicado: (2020)

Comparison of T2 and FLAIR imaging for target delineation in high grade gliomas
por: Stall, Bronwyn, et al.
Publicado: (2010)

A dosimetric comparison of four treatment planning methods for high grade glioma
por: Zach, Leor, et al.
Publicado: (2009)

Disabled cell density sensing leads to dysregulated cholesterol synthesis in glioblastoma
por: Kambach, Diane M., et al.
Publicado: (2017)

mTORC2/Rac1 Pathway Predisposes Cancer Aggressiveness in IDH1-Mutated Glioma
por: Liu, Yang, et al.
Publicado: (2020)

Radiosensitization of glioma cells by modulation of Met signalling with the hepatocyte growth factor neutralizing antibody, AMG102
por: Buchanan, Ian M, et al.
Publicado: (2011)

DDRE-20. TARGETING SPHINGOLIPID PATHWAY REVEALS VULNERABILITY IN IDH1(MUT) GLIOMA
por: Dowdy, Tyrone, et al.
Publicado: (2021)

TBMT-02. APOLLO: RAMAN-BASED PATHOLOGY OF MALIGNANT GLIOMA
por: Lita, Adrian, et al.
Publicado: (2021)

Correlation of Plasma FL Expression with Bone Marrow Irradiation Dose
por: Sproull, Mary, et al.
Publicado: (2013)

SL-BioDP: Multi-Cancer Interactive Tool for Prediction of Synthetic Lethality and Response to Cancer Treatment
por: Deng, Xiang, et al.
Publicado: (2019)

Sphingolipid Pathway as a Source of Vulnerability in IDH1(mut) Glioma
por: Dowdy, Tyrone, et al.
Publicado: (2020)

Association of Circadian Clock Gene Expression with Glioma Tumor Microenvironment and Patient Survival
por: De La Cruz Minyety, Julianie, et al.
Publicado: (2021)

Radiation-induced alternative transcripts as detected in total and polysome-bound mRNA
por: Wahba, Amy, et al.
Publicado: (2017)

Clinical outcome assessment trends in clinical trials—Contrasting oncology and non‐oncology trials
por: Kim, Yeonju, et al.
Publicado: (2023)

Analytical Considerations of Large-Scale Aptamer-Based Datasets for Translational Applications
por: Jiang, Will, et al.
Publicado: (2022)

Glioblastoma cells have increased capacity to repair radiation-induced DNA damage after migration to the olfactory bulb
por: Degorre, Charlotte, et al.
Publicado: (2022)

Probabilistic model checking of cancer metabolism
por: Friedenberg, Meir D., et al.
Publicado: (2022)

Glioblastoma survival is associated with distinct proteomic alteration signatures post chemoirradiation in a large-scale proteomic panel
por: Krauze, Andra Valentina, et al.
Publicado: (2023)

The landscape of the mesenchymal signature in brain tumours
por: Behnan, Jinan, et al.
Publicado: (2019)

Revisiting Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients with Glioblastoma—Proteomic Alteration and Comparison Analysis with the Standard-of-Care Chemoirradiation
por: Krauze, Andra V., et al.
Publicado: (2023)

Post-radiation increase in VEGF enhances glioma cell motility in vitro
por: Kil, Whoon Jong, et al.
Publicado: (2012)

Tumor Immune Microenvironment Landscape in Glioma Identifies a Prognostic and Immunotherapeutic Signature
por: Zhang, Chunyu, et al.
Publicado: (2021)

Identification of a mesenchymal-related signature associated with clinical prognosis in glioma
por: Zhang, Zhengwei, et al.
Publicado: (2021)

Construction of a telomere-related gene signature to predict prognosis and immune landscape for glioma
por: Xie, Qin, et al.
Publicado: (2023)

Metabolic plasticity of IDH1-mutant glioma cell lines is responsible for low sensitivity to glutaminase inhibition
por: Ruiz-Rodado, Victor, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2au39agi2136mv5l0fros2dvqn